Follicular lymphoma (FL) is characterized by a large number of chromosomal aberrations. However, their exact genomic extension and involved target genes remain to be determined. For this purpose, we used array-based intermediate-high resolution genomic profiling in combination with Affymetrix TM gene expression analysis. Tumor specimens from 128 FL patients were analyzed for the presence of genomic aberrations and the results were correlated to clinical data sets and mRNA expression levels. In 114 (89%) of the 128 analyzed cases, a total of 688 genomic aberrations (384 gains/amplifications and 304 losses) were detected. Frequent genomic aberrations were: Ă1p36 (18%), ĂŸ2p15 (24%), Ă3q (14%), Ă6q (25%), ĂŸ7p (19%), ĂŸ7q (23%), ĂŸ8q (14%), Ă9p (16%), Ă11q (15%), ĂŸ12q (20%), Ă13q (11%), Ă17p (16%), ĂŸ18p (18%), and ĂŸ18q (28%). Critical segments of these imbalances were delineated to genomic fragments with a minimum size down to 0.2 Mb. By comparison of these with mRNA gene expression data, putative candidate genes were identified. Moreover, we found that deletions affecting the tumor suppressor gene CDKN2A/B on 9p21 were detected in nontransformed FL grade I-II. For this aberration as well as for Ă6q25 and Ă6q26, an association with inferior survival was observed.